Results 31 to 40 of about 1,444,573 (177)

Agentes anti-inflamatórios de origem natural

open access: yes, 2016
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, Universidade de Lisboa, Faculdade de Farmácia, 2016A inflamação é uma resposta fisiológica natural a um dano tecidular, causado por infeção ou lesão.
Pinto, Sónia Cristina Marques
core   +2 more sources

Nefrotoxicidade por Anti-Inflamatórios / Anti-InflammatoryNephrotoxicity [PDF]

open access: yes, 2021
Os anti-inflamatórios não esteroidais (AINEs) fármacos habitualmente utilizados, que constituem uma das categorias de fármacos mais prescritas em todo mundo, são utilizados no tratamento da dor aguda, moderada e crônica decorrente de processo ...
Chaves, Luís Fernando Ferreira   +1 more
core  

A incidência de úlcera péptica em usuários crônicos de anti-inflamatórios não esteroides [PDF]

open access: yes, 2023
Objetivo: Descrever a correlação entre o uso crônico de anti-inflamatórios não esteroides e a incidência de úlcera péptica. Revisão bibliográfica: Úlcera péptica é uma lesão na mucosa do trato digestivo superior, podendo gerar uma série de complicações ...
Scarin, Giovanna Paes   +10 more
core   +1 more source

Immunotherapy using pullulan‐conjugated Der f 2 allergen in canine atopic dermatitis: An anti‐inflammatory agent‐sparing approach

open access: yesVeterinary Dermatology, Volume 36, Issue 4, Page 443-452, August 2025.
Background – Allergen immunotherapy is used as aetiological treatment for canine atopic dermatitis (cAD). Objective – To assess the anti‐inflammatory agent‐sparing effect over 1 year of immunotherapy using pullulan‐conjugated recombinant Der f 2 (rDf2‐P). Conclusions and Clinical Relevance – Der f 2‐P immunotherapy can lead to a rapid reduction in anti‐
Masahiko Nagata   +7 more
wiley   +1 more source

Label‐Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer

open access: yesOxidative Medicine and Cellular Longevity, Volume 2019, Issue 1, 2019., 2019
Breast cancer is the leading cause of cancer‐associated death among women worldwide. Its high mortality rate is related to resistance towards chemotherapies, which is one of the major challenges of breast cancer research. In this study, we used label‐free mass spectrometry‐ (MS‐) based proteomics to investigate the differences between circulating ...
Bruno R. B. Pires   +8 more
wiley   +1 more source

Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration

open access: yesVeterinary Dermatology, Volume 36, Issue 4, Page 453-461, August 2025.
Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Wendie Roldan Villalobos   +5 more
wiley   +1 more source

A blinded randomised split‐body clinical trial evaluating the effect of fluorescent light energy on antimicrobial management of canine interdigital furunculosis

open access: yesVeterinary Dermatology, Volume 36, Issue 3, Page 291-301, June 2025.
Background – Canine interdigital furunculosis (CIF) is a complex, relapsing inflammatory condition, typically complicated by deep bacterial infections requiring prolonged systemic antibiotics. Hypothesis/Objectives – This split‐body study, where dogs acted as their own control, evaluated whether the adjunctive use of fluorescent light energy (FLE ...
A. Lange   +12 more
wiley   +1 more source

Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis

open access: yesVeterinary Dermatology, Volume 36, Issue 2, Page 165-176, April 2025.
Background – Janus kinase inhibitors (JAKi) have been shown to reduce pruritus and improve associated inflammatory skin lesions in canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, in comparison to oclacitinib, for the control of cAD in a randomised, blinded trial.
Sophie Forster   +4 more
wiley   +1 more source

Efectos sistémicos del tratamiento intralesional con factor de crecimiento epidérmico (Heberprot-P) en pacientes con úlceras de pie diabético

open access: yesAnales de la Academia de Ciencias de Cuba, 2022
Introducción. La infiltración intralesional con factor de crecimiento epidérmico (EGF) ha emergido como alternativa terapéutica para la cicatrización de las úlceras de pie diabético (UPD).
Ariana García Ojalvo   +11 more
doaj  

Treatment of moderate‐to‐severe canine atopic dermatitis with modified‐release mycophenolate (OKV‐1001): A pilot open‐label, single‐arm multicentric clinical trial

open access: yesVeterinary Dermatology, Volume 35, Issue 6, Page 652-661, December 2024.
Background – Mycophenolate is an immunomodulating agent successfully used for the treatment of moderate‐to‐severe atopic dermatitis (AD) in people. Mycophenolate is an effective steroid‐sparing treatment option for use in dogs with inflammatory skin diseases.
Michael Klotsman   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy